Actively Recruiting
CBCT Guided Markerless SBRT for Renal Cell Cancer
Led by Erasmus Medical Center · Updated on 2026-04-08
40
Participants Needed
1
Research Sites
195 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to improve the treatment of kidney tumors using radiotherapy, by investigating whether kidney cancer can be more effectively irradiated with the help of new imaging techniques
CONDITIONS
Official Title
CBCT Guided Markerless SBRT for Renal Cell Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with histologically proven non-metastatic RCC or high suspicion of RCC based on imaging without histological evidence
- No metastatic lesions
- Patients must be 18 years or older
- Ability to understand the requirements of the study and to give written informed consent, as determined by the treating physician.
You will not qualify if you...
- Previous high-dose radiotherapy in the region of the kidney
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Erasmus MC
Rotterdam, South Holland, Netherlands, 3000CA
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here